Alpha Tau Medical Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K, filed on May 18, 2026, by Alpha Tau Medical Ltd., a foreign private issuer, serves to furnish documents related to the Company's upcoming Annual General Meeting of Shareholders. The meeting is scheduled for June 23, 2026, at the Company's headquarters in Jerusalem, Israel.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a procedural filing regarding shareholder governance and does not contain financial statements or performance data.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing focuses solely on the administrative details of the shareholder meeting.
Guidance, Outlook, and Risks
The document contains no management commentary, financial guidance, or discussion of risks and contingencies. It strictly outlines the notice and proxy statement for the annual meeting, including voting procedures and proposals to be voted upon.
Key Facts for Investors
- Meeting Date: June 23, 2026, at 4:00 p.m. Israel time.
- Location: 5 Kiryat Hamada St., Jerusalem, Israel.
- Documents Furnished: Notice and proxy statement (Exhibit 99.1) and proxy card (Exhibit 99.2).
- Signatory: Uzi Sofer, Chief Executive Officer.
- Financial Data: None included in this specific filing.